References
[1] Siegel JA, Pennington CW, Sacks B. Subjecting radiological imaging to the linear no-threshold hypothesis: a non sequitur of non-trivial proportion. J Nucl Med. 2017; 58(1):1-6. [2] Siegel JA, Stabin MG. RADAR commentary: use of linear no-threshold hypothesis in radiation protection regulation in the United States. Health Phys. 2012; 102:90-99. [3] Brooks AL, Dauer LT. Advances in radiation biology: effect on nuclear medicine. Semin Nucl Med. 2014; 44:179-186. [4] Koana T, Tsujimura H. A U-shaped dose-response relationship between x radiation and sex-linked recessive lethal mutation in male germ cells of Drosophila. Radiat Res. 2010; 174:46-51. [5] Luckey TD Radiation hormesis. Boca Raton, FL: CRC Press; 1991. [6] Feinendegen LE, Pollycove M, Neumann RD. Low-dose cancer risk modeling must recognize up-regulation of protection. Dose-Response. 2010; 8:227–252. [7] Löbrich M, Rief N, Kühne M, et al. In vivo formation and repair of DNA double-strand breaks after computed tomography examinations. Proc Natl Acad Sci. 2005; 102(25):8984-8989. [8] Siegel JA, Silberstein EB. A closer look at the latest NRC patient release guidance. J Nucl Med. 2008; 49:17N-20N. [9] Sacks B, Meyerson G, Siegel JA. Epidemiology without biology: false paradigms, unfounded assumptions, and specious statistics in radiation science (with commentaries by Inge Schmitz-Feuerhake and Christopher Busby and a reply bythe authors). Biol Theory. 2016;11:69–101. [10] Grant EJ, Brenner A, Sugiyama H, et al. Solid cancer incidence among the Life Span Study of Atomic Bomb Survivors: 1958–2009. 2017; Radiat. Res. 187; http://www.rerf.or.jp. Accessed May 5, 2017 [11] Ozasa K. Epidemiological research on radiation-induced cancer in atomic bomb survivors. J Radiat Res. 57(Suppl 1),March 2016; doi: 10.1093/jrr/rrw005 [12] Taylor LS. Some nonscientific influences on radiation protection standards and practice: the 1980 Sievert lecture. Health Phys. 1980; 39:851-874. [13] Chen D, Wei L. Chromosome aberration, cancer mortality and hormetic phenomena among inhabitants in areas of high background radiation in China. J Radiat Res. 1991; Suppl; 2:46-53. [14] Russo GL, Tedesco I, Russo M, et al. Cellular adaptive response to chronic radiation exposure in interventional cardiologists. Eur Heart J. 2012; 33:408–414. [15] Van Nostrand D. Prescribed activity of 131I therapy in differentiated thyroid cancer. J Nucl Med. 2017; DOI: 10.2967/jnumed.116.188862.